[HTML][HTML] Anti-SARS-CoV natural products with the potential to inhibit SARS-CoV-2 (COVID-19)

S Verma, D Twilley, T Esmear… - Frontiers in …, 2020 - frontiersin.org
… This includes the novel SARS-CoV-2, which is responsible for causing the coronavirus
disease of 2019 (COVID-19). Other coronaviruses include the alpha coronaviruses (HCoVs-NL-…

SARSCoV‐2 endothelial infection causes COVID19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases

I Colmenero, C Santonja… - British journal of …, 2020 - academic.oup.com
… infection by SARSCoV‐2 could have a pathogenetic role in the severe forms of COVID19. …
and young adults during the coronavirus disease 2019 (COVID19) pandemic worldwide. …

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

E Ortiz-Prado, K Simbaña-Rivera… - … and infectious disease, 2020 - Elsevier
SARS CoV, MERS-CoV and SARS CoV-2 virus. They are responsible for causing severe
acute respiratory syndrome (SARS), … and the severity of COVID-19, which we discuss below. …

Sustainability of supply chains in the wake of the coronavirus (COVID-19/SARS-CoV-2) pandemic: lessons and trends

ABL de Sousa Jabbour, CJC Jabbour… - Modern supply chain …, 2020 - emerald.com
… The purpose of this article is to address the prioritisation and focus of supply chain
managers subsequent to coronavirus disease 2019 (COVID-19)/severe acute respiratory …

SARS-CoV-2 reinfection and COVID-19 severity

NN Nguyen, L Houhamdi, VT Hoang… - Emerging microbes & …, 2022 - Taylor & Francis
… of the second episode of COVID-19 is in the same range as … from COVID-19, 87 had no
detectable IgG against SARS-CoV-… our centre in 46 reinfected COVID-19 patients, the proportion …

[PDF][PDF] Coronavirus covid-19 (sars-cov-2)

PG Auwaerter - Johns Hopkins ABX Guide, 2020 - landmarkaesthetics.net
… : o Coronavirus for common human respiratory coronavirus infections. o SARS for the
SARS-CoV … o MERS for the MERS-CoV virus, causing sporadic infections, mostly in the Arabian …

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

DR Owen, CMN Allerton, AS Anderson… - Science, 2021 - science.org
… severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has … COVID-19. Here,
we report the discovery and characterization of PF-07321332, an orally bioavailable SARS-CoV-…

[HTML][HTML] SARS-CoV-2 genomic variations associated with mortality rate of COVID-19

Y Toyoshima, K Nemoto, S Matsumoto… - Journal of human …, 2020 - nature.com
… showing different fatality rates of COVID-19. In correlation analyses, we … Our findings suggest
that SARS-CoV-2 mutations as well as … to SARS-CoV-2 infection or severity of COVID-19. …

COVID-19: gastrointestinal symptoms and potential sources of SARS-CoV-2 transmission

K Kotfis, K Skonieczna-Żydecka - Anaesthesiology intensive therapy, 2020 - termedia.pl
… of COVID-19, but little is known about SARS-CoV-2 liver infection. In previous SARS
studies, almost 60% of patients presented with liver problems. The presence of SARS genetic …

Persistence of SARS-CoV-2 in the environment and COVID-19 transmission risk from environmental matrices and surfaces

F Carraturo, C Del Giudice, M Morelli, V Cerullo… - Environmental …, 2020 - Elsevier
… The main results of the researches conducted on SARS-CoV-2 surrogate strains (SARS-CoV,
and H–CoV-229) are showed in Table 3. The COVID-19 is caused by SARS-CoV-2: recent …